Combined urine test for T2:ERG, PCA3 ups prostate CA detection

Combined urine test for <i>T2:ERG</i>, <i>PCA3</i> ups prostate CA detec

(HealthDay)—Testing for combined urinary PCA3 and TMPRSS2:ERG (T2:ERG) RNA can improve detection of prostate cancer, according to a study published online May 18 in JAMA Oncology.

Martin G. Sanda, M.D., from the Emory University School of Medicine in Atlanta, and colleagues conducted a multicenter diagnostic evaluation and validation in academic and community-based ambulatory urology clinics. A sample of men presenting for first-time without preexisting prostate cancer were enrolled: 516 in the developmental cohort and 561 in the validation cohort. Urinary PCA3 and T2:ERG RNA were measured before prostate biopsy.

The researchers found that at thresholds that preserved 95 percent sensitivity for detecting aggressive prostate cancer, combining testing of urinary T2:ERG and PCA3 improved specificity from 18 to 39 percent in the developmental cohort. Improvement of specificity was also seen in the validation cohort (from 17 to 33 percent), while for aggressive prostate detection, high sensitivity (93 percent) was preserved. Using the urine assay results to select men for biopsy would have resulted in 42 percent of unnecessary prostate biopsies being averted. In cost analysis, the urinary testing algorithm was found to have greater potential benefit for restricting biopsy in younger men.

"Combined urinary testing for T2:ERG and PCA3 can avert unnecessary while retaining robust sensitivity for detecting aggressive with consequent potential health care cost savings," the authors write.

Several authors disclosed financial ties to pharmaceutical and diagnostic companies, including Hologic, which manufactures the Progensa PCA3 assay and is a licensee of the diagnostic field of use for T2:ERG.


Explore further

PCA3 assay ups predictive accuracy for repeat biopsy

More information: Abstract/Full Text
Journal information: JAMA Oncology

Copyright © 2017 HealthDay. All rights reserved.

Citation: Combined urine test for T2:ERG, PCA3 ups prostate CA detection (2017, May 22) retrieved 20 July 2019 from https://medicalxpress.com/news/2017-05-combined-urine-t2erg-pca3-ups.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more